Brian Orr

3PUBLICATIONS
48CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 03, 2024
MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model.

Alexandra Blackman, Amy C Rees, Robert R Bowers

|Jan 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity.

Brian Orr, Haider Mahdi, Yusi Fang

|Dec 08, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.

Christopher A Chuckran, Anthony R Cillo, Jessica Moskovitz

Pageof 1